Shalby Limited — Investor Meet, 06-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

Shalby Limited reported Q2 FY25 results, showcasing a consolidated revenue of ₹275 crore, up 12.9% year-on-year. However, EBITDA declined by 31.5% to ₹39.8 crore, leading to a 4.9% profit before tax. Delayed surgeries due to monsoon rains affected performance. The standalone hospital revenue decreased by 2.4%. The company emphasized ongoing growth plans, including acquiring new hospitals and expanding its implant business, which saw 90% revenue growth. Shalby's focus on operational efficiency aims to recover profitability.